Close

Advanced Zebrafish Monoclonal Antibody Discovery Service

Background Technology Workflow Advantage Related Services FAQ Online Inquiry

In the contemporary landscape of biomedical research, the zebrafish has emerged as an indispensable vertebrate model system for studying developmental biology, toxicology, and human disease pathogenesis. To empower researchers with high-specificity tools, Creative Biolabs provides a comprehensive, end-to-end Zebrafish Monoclonal Antibody Discovery service. Leveraging our world-leading phage display technology and decades of expertise in immune antibody library engineering, we deliver high-affinity Zebrafish Monoclonal Antibodies tailored to your specific research and diagnostic (non-clinical) needs.

Discuss Your Project Today

Overview of Zebrafish Monoclonal Antibody Discovery

Zebrafish offer a unique immunological repertoire. Unlike mammalian models, teleost fish utilize three distinct immunoglobulin (Ig) classes: IgM, IgD, and the fish-specific IgZ (analogous to mammalian IgA in mucosal immunity). Utilizing Zebrafish Monoclonal Antibody Discovery allows for the identification of binders that recognize epitopes often conserved across species or those that are non-immunogenic in traditional rodent models.

At Creative Biolabs, we specialize in the construction and screening of immune antibody library systems derived from zebrafish. By utilizing phage display-based Zebrafish Monoclonal Antibody discovery, we bypass the limitations of traditional hybridoma technology—such as low fusion efficiency and the instability of fish-mouse heterohybridomas—to provide a robust, recombinant solution for antibody production.

Fig. 1 Zebrafish. (Creative Biolabs Authorized)

Technical Excellence: Phage Display-Based Zebrafish Monoclonal Antibody Discovery

The cornerstone of our service is the integration of phage display with a sophisticated immune antibody library for Zebrafish Monoclonal Antibody discovery. Our platform is designed to capture the full diversity of the zebrafish immune response following antigen challenge.

The Mechanism of Phage Display in Fish Models

Phage display involves the fusion of antibody fragments (typically scFv or Fab) to the coat proteins (pIII or pVIII) of filamentous bacteriophages. This creates a physical link between the phenotype (antibody binding) and the genotype (the DNA sequence). For Zebrafish Monoclonal Antibody projects, we clone the V-gene repertoire from zebrafish B-lymphocytes into phagemid vectors, ensuring that the resulting immune antibody library accurately reflects the animal's natural immune response.

Workflow: Construction and Screening of Immune Antibody Library

Our Zebrafish Monoclonal Antibody Discovery process is a meticulously orchestrated pipeline, ensuring the highest success rate for even the most challenging antigens.

01Antigen Design and Zebrafish Immunization

Successful Zebrafish Monoclonal Antibody generation begins with optimal immunization. We utilize high-purity proteins, peptides, or even whole cells as immunogens. Our proprietary adjuvant formulations are optimized for teleost fish to maximize the titers of IgM and IgZ-secreting B cells.

02Total RNA Extraction and cDNA Synthesis

Following a confirmed immune response (monitored via ELISA), we harvest the spleen and kidney (the primary hematopoietic organs in zebrafish). Total RNA is extracted to provide a template for cDNA synthesis, targeting the immunoglobulin heavy and light chain constant regions.

03V-Gene Amplification and Library Construction

Using a comprehensive set of degenerate primers specifically designed for zebrafish V-gene families (VH, VL, Vλ), we amplify the variable regions.

  • scFv Format: VH and VL are linked by a flexible (Gly4Ser)3 linker.
  • Fab Format: Full VH-CH1 and VL-CL regions are cloned.

Our construction and screening of immune antibody library protocols ensure a library size of at least 108 to 109 independent clones, capturing the maximum depth of the immune repertoire.

04Biopanning and High-Throughput Screening

We employ stringent biopanning strategies to isolate high-affinity binders from the immune antibody library for Zebrafish Monoclonal Antibody.

  • Solid-phase panning: Antigen immobilized on immunotubes or ELISA plates.
  • Solution-phase panning: Biotinylated antigens captured by streptavidin-coated magnetic beads.
  • Subtractive panning: To eliminate non-specific binders and cross-reactivity.
05Antibody Validation and Characterization

Selected clones are expressed as soluble proteins and subjected to rigorous validation, including:

  • Affinity Measurement: SPR (Biacore) or BLI (Octet).
  • Specificity Testing: Cross-reactivity analysis against related proteins.
  • Application Testing: Western Blot (WB), Immunofluorescence (IF), and Immunohistochemistry (IHC) on zebrafish tissue sections.

Why Choose Creative Biolabs for Your Zebrafish Antibody Needs?

Creative Biolabs stands at the forefront of Zebrafish Monoclonal Antibody Discovery. By combining the power of phage display with our deep expertise in immune antibody library technology, we provide the global scientific community with high-performance tools to unlock the secrets of zebrafish biology. Our commitment to quality and innovation ensures that your research is supported by the finest Zebrafish Monoclonal Antibodies available in the industry.

Explore Our Comprehensive Services

While our phage display immune antibody library platform is a powerful engine, we offer a comprehensive suite of discovery technologies to ensure we always use the right tool for the job. Our Monoclonal Antibody Generation from Various Immunized Antibody Libraries Services:

Contact us today to discuss your specific requirements for Zebrafish Monoclonal Antibody Discovery by phage display and let our experts design a customized strategy for your success.

Contact Us Today for a Free Quote!

Frequently Asked Questions (FAQs)

  1. Q: Why is phage display preferred over hybridoma for zebrafish monoclonal antibody discovery?

    A: Hybridoma technology in fish is notoriously difficult due to the lack of stable myeloma fusion partners and lower fusion efficiencies. Phage display allows us to capture the immune repertoire as DNA, which is infinitely more stable and allows for high-throughput in vitro selection of Zebrafish Monoclonal Antibodies without the need for cell fusion.

  2. Q: How large is the immune antibody library for Zebrafish Monoclonal Antibody discovery?

    A: We typically guarantee a library size of 108 to 109 independent transformants. This ensures that even rare B-cell clones responding to low-abundance epitopes are captured during the construction and screening of immune antibody library.

  3. Q: Can you produce antibodies that cross-react with both zebrafish and human orthologs?

    A: Yes. Through our "cross-species" panning strategy, we can alternate the antigen between the zebrafish protein and the human ortholog during different rounds of biopanning to isolate clones that recognize conserved epitopes.

  4. Q: Is the Zebrafish Monoclonal Antibody suitable for Immunohistochemistry (IHC)?

    A: Absolutely. Our screening process includes validation on native proteins and tissue sections to ensure the antibodies perform excellently in IHC, IF, and other platform-based assays.

Reference

  1. Anderson, Amy L., et al. "Development and applications of a zebrafish (Danio rerio) CYP1A-targeted monoclonal antibody (CRC4) with reactivity across vertebrate taxa: evidence for a conserved CYP1A epitope." Toxics 10.7 (2022): 404. https://doi.org/10.3390/toxics10070404

×
Online Inquiry

All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.

Our customer service representatives are available 24 hours a day, 7 days a week. Contact Us
© 2026 Creative Biolabs. | Contact Us